INTERNATIONAL SOCIETY FOR PHARMACEUTICAL ENGINEERING INC (EIN 561780932) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1992

Legal Domicile

Principal Officer

CHRIS SMITH

Phone

9194592070

Tax Period

2024-01-01 to 2024-12-31

INTERNATIONAL SOCIETY FOR PHARMACEUTICAL ENGINEERING INC, founded in 1992, is a community nonprofit that reported $1.4M in total revenue in fiscal year 2024. Revenue surged 29% from the prior year, signaling strong growth momentum. The organization ran a surplus of $232K, a strong 16% operating margin.

Mission

TO DEFINE AND ADDRESS THE LOCAL NEEDS OF ENGINEERS AND OTHER TECHNICAL PROFESSIONALS IN THE REGULATED HEALTHCARE MANUFACTURING INDUSTRY IN ACCORDANCE WITH THE SOCIETY'S OBJECTIVES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $1,428,536

Investment Income $0

Other Revenue $0

TOTAL REVENUE $1,428,536

Expense Breakdown

Grants Paid $20,512

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $1,176,134

TOTAL EXPENSES $1,196,646

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,428,536	$1,110,389	+0.3%
Expenses	$1,196,646	$941,694	+0.3%
Net Income	$231,890	$168,695	+0.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JULIE BARBERIO	SECRETARY	N/A	Officer Director	$0	$0	$0
MARC BONNER	DIRECTOR	N/A	Director	$0	$0	$0
LISA BURLESON	DIRECTOR	N/A	Director	$0	$0	$0
ANDREW CAMPBELL	DIRECTOR	N/A	Director	$0	$0	$0
CLAYTON CAREY	DIRECTOR	N/A	Director	$0	$0	$0
KAKKI COLLINS	DIRECTOR	N/A	Director	$0	$0	$0
CHANDLER CONLEY	DIRECTOR	N/A	Director	$0	$0	$0
CHARLES CROSIER	DIRECTOR	N/A	Director	$0	$0	$0
HADASSAH ELEY	VICE PRESIDE	N/A	Officer Director	$0	$0	$0
JOHN GARNER	DIRECTOR	N/A	Director	$0	$0	$0
JANET GLASGOW	DIRECTOR	N/A	Director	$0	$0	$0
CHRIS GULLETTE	DIRECTOR	N/A	Director	$0	$0	$0
MATT JANICKE	DIRECTOR	N/A	Director	$0	$0	$0
BEN LYONS	DIRECTOR	N/A	Director	$0	$0	$0
AEONA MAGLIOLA	DIRECTOR	N/A	Director	$0	$0	$0
SHANNON MANNING	DIRECTOR	N/A	Director	$0	$0	$0
JENNIFER MITCHELL	DIRECTOR	N/A	Director	$0	$0	$0
ALMA MONTEMAYOR	PAST PRESIDE	N/A	Officer Director	$0	$0	$0
ZACHARY PARRISH	DIRECTOR	N/A	Director	$0	$0	$0
JENNIFER POPOVICH	DIRECTOR	N/A	Director	$0	$0	$0
ROSS RUBEL	DIRECTOR	N/A	Director	$0	$0	$0
MELODY SCOTT	DIRECTOR	N/A	Director	$0	$0	$0
COURTNEY SKUNDA-HALL	TREASURER	N/A	Officer Director	$0	$0	$0
CHRIS SMITH	PRESIDENT	N/A	Officer Director	$0	$0	$0
BRIAN STANCEL	DIRECTOR	N/A	Director	$0	$0	$0
PHIL TODARO	DIRECTOR	N/A	Director	$0	$0	$0
MICHAEL ZIVITZ	DIRECTOR	N/A	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$1,428,536	$1,196,646	$1,944,466	$231,890
2023	$1,110,389	$941,694	$1,258,817	$168,695
2022	$688,141	$551,968	$1,250,322	$136,173
2021	$180,294	$235,302	$877,210	$-55,008
2020	$404,275	$295,082	$602,230	$109,193
2019	$529,020	$402,141	$754,075	$126,879
2018	$488,744	$375,719	$541,644	$113,025

INTERNATIONAL SOCIETY FOR PHARMACEUTICAL ENGINEERING INC